Vor Biopharma Inc. Contracts & Agreements

Sales Agreement, dated December 23, 2022, by and between the Company and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on December 23, 2022)

Underwriting Agreement, dated as of December 7, 2022, by and among Vor Biopharma Inc. and Evercore Group L.L.C. and Stifel, Nicolaus & Company, Incorporated, as representatives of... (Filed With SEC on December 7, 2022)

Securities Purchase Agreement, dated as of December 7, 2022, by and between Vor Biopharma Inc. and RA Capital Healthcare Fund, L.P (Filed With SEC on December 7, 2022)

Separation Agreement, by and between the Registrant and Christopher Slapak, dated May 11, 2022 (Filed With SEC on August 11, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 14, 2022)

Second Amendment to Exclusive License Agreement, by and between the Registrant and The Trustees of Columbia University in the City of New York, dated November 8, 2021 (Filed With SEC on November 10, 2021)

First Amendment to Lease, by and between the Company and PPF Off 100 Cambridge Park Drive, LLC (Landlord), dated June 15, 2021 (Filed With SEC on June 17, 2021)

Second Amendment to Lease, by and between the Company and the Landlord, dated June 15, 2021 (Filed With SEC on June 17, 2021)

Form of Underwriting Agreement (Filed With SEC on February 1, 2021)

Form of Common Stock Certificate of the Registrant (Filed With SEC on February 1, 2021)

Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated June 30, 2020 (Filed With SEC on February 1, 2021)

2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement (Filed With SEC on February 1, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)

Non-Employee Director Compensation Policy (Filed With SEC on February 1, 2021)

Executive Severance and Change in Control Benefits Plan (Filed With SEC on February 1, 2021)

Exclusive License Agreement, by and between the Registrant and The Trustees of Columbia University in the City of New York, dated April 28, 2016 (Filed With SEC on January 15, 2021)

First Amendment to Exclusive License Agreement, by and between the Registrant and The Trustees of Columbia University in the City of New York, dated February 12, 2019 (Filed With SEC on January 15, 2021)

Patent License Agreement, by and between the Registrant and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, dated October 30,... (Filed With SEC on January 15, 2021)

Lease Agreement, by and between the Registrant and PPF Off 100 Cambridge Park Drive, LLC, dated December 17, 2019 (Filed With SEC on January 15, 2021)

2015 Stock Incentive Plan and Forms of Option Grant Agreements, Exercise Notices and Restricted Stock Agreement (Filed With SEC on January 15, 2021)

Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on January 15, 2021)

Offer Letter, by and between the Registrant and Robert Ang, dated June 28, 2019 (Filed With SEC on January 15, 2021)

Offer Letter, by and between the Registrant and Sadik Kassim, dated August 12, 2019 (Filed With SEC on January 15, 2021)

Offer Letter, by and between the Registrant and Christopher Slapak, dated July 2, 2020 (Filed With SEC on January 15, 2021)

Offer Letter, by and between the Registrant and Nathan Jorgensen, dated March 20, 2020 (Filed With SEC on January 15, 2021)

Offer Letter, by and between the Registrant and Tirtha Chakraboty, dated August 28, 2019 (Filed With SEC on January 15, 2021)